According to the research report, the global antibody production market size is expected to touch USD 66.26 Billion by 2032, from USD 19.4 Billion in 2022, growing with a significant CAGR of 13.07% from 2023 to 2032.
Key Takeaways:
- North America contributed more than 40% of revenue share in 2022.
- By Poduct, the consumables segment generated with a largest market share of 57% in 2022.
- By Process, the downstream segment held the highest market share of 68% in 2022.
- By Type, the monoclonal antibody segment recorded more than 65% of revenue share in 2022.
- By End-use, the pharmaceutical and biotechnology companies segment captured more than 56% of revenue share in 202
The antibody production report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global antibody production in conjunction with the geographical landscape of this vertical have also been included in this report.
The report offers intricate dynamics about different aspects of the global antibody production market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global antibody production during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).
Sample Link @ https://www.precedenceresearch.com/sample/3212
This study covers a detailed segmentation of the global antibody production market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global antibody production market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.
Key Players
- QIAGEN
- Thermo Fisher Scientific, Inc.
- PerkinElmer, Inc.
- BGI
- Illumina, Inc.
- Agilent Technologies
- Pacific Biosciences of California, Inc.
- ProPhase Labs, Inc. (Nebula Genomics)
- Psomagen
- Azenta US, Inc.
Market Segmentation
By Product
- Instruments
- Consumables
- Software
By Process
- Upstream Processing
- Downstream Processing
By Type
- Monoclonal Antibody
- Polyclonal Antibody
By End-use
- Pharmaceutical and Biotechnology Companies
- Research Laboratories
- CROs and CDMOs
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Research Methodology
The research methodology adopted by analysts for compiling the global antibody production report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.
During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.
For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global antibody production market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Antibody Production Market
5.1. COVID-19 Landscape: Antibody Production Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Antibody Production Market, By Product
8.1. Antibody Production Market Revenue and Volume Forecast, by Product, 2023-2032
8.1.1. Instruments
8.1.1.1. Market Revenue and Volume Forecast (2020-2032)
8.1.2. Consumables
8.1.2.1. Market Revenue and Volume Forecast (2020-2032)
8.1.3. Software
8.1.3.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 9. Global Antibody Production Market, By Process
9.1. Antibody Production Market Revenue and Volume Forecast, by Process, 2023-2032
9.1.1. Upstream Processing
9.1.1.1. Market Revenue and Volume Forecast (2020-2032)
9.1.2. Downstream Processing
9.1.2.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 10. Global Antibody Production Market, By Type
10.1. Antibody Production Market Revenue and Volume Forecast, by Type, 2023-2032
10.1.1. Monoclonal Antibody
10.1.1.1. Market Revenue and Volume Forecast (2020-2032)
10.1.2. Polyclonal Antibody
10.1.2.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 11. Global Antibody Production Market, By End-use
11.1. Antibody Production Market Revenue and Volume Forecast, by End-use, 2023-2032
11.1.1. Pharmaceutical and Biotechnology Companies
11.1.1.1. Market Revenue and Volume Forecast (2020-2032)
11.1.2. Research Laboratories
11.1.2.1. Market Revenue and Volume Forecast (2020-2032)
11.1.3. CROs and CDMOs
11.1.3.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 12. Global Antibody Production Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.1.2. Market Revenue and Volume Forecast, by Process (2020-2032)
12.1.3. Market Revenue and Volume Forecast, by Type (2020-2032)
12.1.4. Market Revenue and Volume Forecast, by End-use (2020-2032)
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.1.5.2. Market Revenue and Volume Forecast, by Process (2020-2032)
12.1.5.3. Market Revenue and Volume Forecast, by Type (2020-2032)
12.1.5.4. Market Revenue and Volume Forecast, by End-use (2020-2032)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.1.6.2. Market Revenue and Volume Forecast, by Process (2020-2032)
12.1.6.3. Market Revenue and Volume Forecast, by Type (2020-2032)
12.1.6.4. Market Revenue and Volume Forecast, by End-use (2020-2032)
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.2.2. Market Revenue and Volume Forecast, by Process (2020-2032)
12.2.3. Market Revenue and Volume Forecast, by Type (2020-2032)
12.2.4. Market Revenue and Volume Forecast, by End-use (2020-2032)
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.2.5.2. Market Revenue and Volume Forecast, by Process (2020-2032)
12.2.5.3. Market Revenue and Volume Forecast, by Type (2020-2032)
12.2.5.4. Market Revenue and Volume Forecast, by End-use (2020-2032)
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.2.6.2. Market Revenue and Volume Forecast, by Process (2020-2032)
12.2.6.3. Market Revenue and Volume Forecast, by Type (2020-2032)
12.2.6.4. Market Revenue and Volume Forecast, by End-use (2020-2032)
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.2.7.2. Market Revenue and Volume Forecast, by Process (2020-2032)
12.2.7.3. Market Revenue and Volume Forecast, by Type (2020-2032)
12.2.7.4. Market Revenue and Volume Forecast, by End-use (2020-2032)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.2.8.2. Market Revenue and Volume Forecast, by Process (2020-2032)
12.2.8.3. Market Revenue and Volume Forecast, by Type (2020-2032)
12.2.8.4. Market Revenue and Volume Forecast, by End-use (2020-2032)
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.3.2. Market Revenue and Volume Forecast, by Process (2020-2032)
12.3.3. Market Revenue and Volume Forecast, by Type (2020-2032)
12.3.4. Market Revenue and Volume Forecast, by End-use (2020-2032)
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.3.5.2. Market Revenue and Volume Forecast, by Process (2020-2032)
12.3.5.3. Market Revenue and Volume Forecast, by Type (2020-2032)
12.3.5.4. Market Revenue and Volume Forecast, by End-use (2020-2032)
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.3.6.2. Market Revenue and Volume Forecast, by Process (2020-2032)
12.3.6.3. Market Revenue and Volume Forecast, by Type (2020-2032)
12.3.6.4. Market Revenue and Volume Forecast, by End-use (2020-2032)
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.3.7.2. Market Revenue and Volume Forecast, by Process (2020-2032)
12.3.7.3. Market Revenue and Volume Forecast, by Type (2020-2032)
12.3.7.4. Market Revenue and Volume Forecast, by End-use (2020-2032)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.3.8.2. Market Revenue and Volume Forecast, by Process (2020-2032)
12.3.8.3. Market Revenue and Volume Forecast, by Type (2020-2032)
12.3.8.4. Market Revenue and Volume Forecast, by End-use (2020-2032)
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.4.2. Market Revenue and Volume Forecast, by Process (2020-2032)
12.4.3. Market Revenue and Volume Forecast, by Type (2020-2032)
12.4.4. Market Revenue and Volume Forecast, by End-use (2020-2032)
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.4.5.2. Market Revenue and Volume Forecast, by Process (2020-2032)
12.4.5.3. Market Revenue and Volume Forecast, by Type (2020-2032)
12.4.5.4. Market Revenue and Volume Forecast, by End-use (2020-2032)
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.4.6.2. Market Revenue and Volume Forecast, by Process (2020-2032)
12.4.6.3. Market Revenue and Volume Forecast, by Type (2020-2032)
12.4.6.4. Market Revenue and Volume Forecast, by End-use (2020-2032)
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.4.7.2. Market Revenue and Volume Forecast, by Process (2020-2032)
12.4.7.3. Market Revenue and Volume Forecast, by Type (2020-2032)
12.4.7.4. Market Revenue and Volume Forecast, by End-use (2020-2032)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.4.8.2. Market Revenue and Volume Forecast, by Process (2020-2032)
12.4.8.3. Market Revenue and Volume Forecast, by Type (2020-2032)
12.4.8.4. Market Revenue and Volume Forecast, by End-use (2020-2032)
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.5.2. Market Revenue and Volume Forecast, by Process (2020-2032)
12.5.3. Market Revenue and Volume Forecast, by Type (2020-2032)
12.5.4. Market Revenue and Volume Forecast, by End-use (2020-2032)
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.5.5.2. Market Revenue and Volume Forecast, by Process (2020-2032)
12.5.5.3. Market Revenue and Volume Forecast, by Type (2020-2032)
12.5.5.4. Market Revenue and Volume Forecast, by End-use (2020-2032)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.5.6.2. Market Revenue and Volume Forecast, by Process (2020-2032)
12.5.6.3. Market Revenue and Volume Forecast, by Type (2020-2032)
12.5.6.4. Market Revenue and Volume Forecast, by End-use (2020-2032)
Chapter 13. Company Profiles
13.1. QIAGEN
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Thermo Fisher Scientific, Inc.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. PerkinElmer, Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. BGI
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Illumina, Inc.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Agilent Technologies
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Pacific Biosciences of California, Inc.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. ProPhase Labs, Inc. (Nebula Genomics)
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Psomagen
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Azenta US, Inc.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments